Discover a new way to find and share stories you'll love… Learn about Reading Desk

Search Results : Human Genome Sciences


Blog Post Results (101-120 of 324)

Art and science: "Your Inner Neanderthal"

3 years agoOdd : Boing Boing

If you're in the Twin Cities area on Saturday, April 28th, I recommend going to check out artist and science geek Lynn Fellman talk about the Neanderthal contribution to the modern human genome, and how art can help people understand complicated science. "Your Inner Neanderthal" is part of the Hennepin County Library's DNA Days events. [...]

For Sale, Just Not at That Price

Human Genome Sciences rejects Glaxo's offer, but is open to a sale.

Dealpolitik: Is Human Genome Sciences Trying to ‘Roche’ Glaxo?

Illumina?s management didn?t just squeak by in its proxy fight with Roche. It delivered a stunning trouncing to Roche and its $51 per share cash bid for Illumina. And the lessons learned from Roche?s missteps may already be impacting the takeover world, as evidenced perhaps is Human Genome Science?s handling this week of an overture from GlaxoSmithKline.

Chemistry World’s roundup of money and molecules

GSK sells more brands – Roche abandons Illumina chase – And Lonza to develop bee silk products PHARMACEUTICAL – The reports are confirmed: GlaxoSmithKline (GSK) is looking to buy long term partner Human Genome Sciences (HGS). The UK pharma giant offered $2.6 billion (£1.6 billion) but was immediately rebuffed by HGS, which said ‘the offer [...]

2 Biotechs Absolutely Crushing It

Human Genome Sciences' takeover and Gilead's hep-C drug rock.

GlaxoSmithKline bids for Human Genome

Human Genome Sciences said it had rejected an unsolicited bid worth around $2.6 billion from GlaxoSmithKline. ||| Human Genome Sciences Inc said it had rejected an unsolicited bid worth around $2.6 billion from long-time partner GlaxoSmithKline, marking a new takeover battle in a drugs sector that has been swept by M&A recently. Show More Summary

Market Check: Gilead, Human Genome Lead Biotech Surge

Biotechnology is seeing strong gains in U.S. exchange-traded funds today after GlaxoSmithKline PLC (GSK) confirmed it made an unsolicited offer to buy Human Genome Sciences (HGSI) for $2.6 billion, spurring the target’s stock to double in price today. Also helping is news that a hepatitis C treatment by Gilead Sciences (GILD) and Bristol-Myers Squibb (BMY) has showed progress, [...]

GlaxoSmithKline pounces on Human Genome with $2.6 billion bid | Reuters

via reuters.com (Reuters) - Human Genome Sciences has rejected an unsolicited bid worth around $2.6 billion from long-time partner GlaxoSmithKline, marking a new takeover battle in a drugs sector swept by M&A activity recently. The pioneer...Show More Summary

Human Genome Sciences and Gilead Sciences Among Most Active Stocks in Pre-Market Today

The three most active stocks and funds in pre-market trading on the Nasdaq were Human Genome Sciences (HGSI) Gilead Sciences (GILD) and PowerShares QQQ (QQQ) as of 9:10 a.m. Investors traded 15 547 055 shares of Human Genome Sciences which was up $7.28 or 101.53%. Show More Summary

Stocks To Watch: Bank of America, EBay, Morgan Stanley

Among the companies with shares expected to actively trade in Thursday's session are Bank of America, eBay and Human Genome Sciences.

A.M. Vitals: Human Genome Sciences Rejects Glaxo’s $2.6 Billion Bid

Also: A study suggests exercise helps ward of Alzheimer's, even in patients over 80 years old; U.S. officials seize contaminated ultrasound gel; and a combination of Hepatitis C drugs show promise.

Human Genome Sciences Rejects $2.59 Billion Offer From GlaxoSmithKline

The biotechnology company Human Genome Sciences rejected a $2.58 billion takeover bid by the British drugmaker GlaxoSmithKline on Thursday.

Aggressive Prostate Cancer Risk Linked With Two Genetic Deletions In Human Genome

According to a study published online in Proceedings of the National Academy of Sciences (PNAS), researchers have identified two inherited-genetic deletions in the human genome associated to the development of prostate cancer. The study,...Show More Summary

Jon Agar: 13 Awesome Moments In Science History (PHOTOS)

3 years agoNews : Huffington Post

Science has been at the heart of twentieth-century history - from Einstein's new physics to the Manhattan Project, from eugenics to the Human Genome Project, or from the wonders of penicillin to the promises of biotechnology.

No comments please, we’ve made it through peer review (?)

Recently Daniel MacArthur pointed to the vibrant discussion over at Genomes Unzipped on a moderately infamous paper from Science last year, Widespread RNA and DNA Sequence Differences in the Human Transcriptome, asserting that it is “exactly what open peer review should be like.”  This made me wonder, it’s been over five years since Chris Surridge [...]

Previously Unknown Cause Of Epilepsy Revealed By Genome Sequencing

Only 10 years ago, deciphering the genetic information from one individual in a matter of weeks to find a certain disease-causing genetic mutation would have been written off as science fiction. It was the time of the Human Genome Project,...Show More Summary

Genome sequencing finds unknown cause of epilepsy

Only 10 years ago, deciphering the genetic information from one individual in a matter of weeks to find a certain disease-causing genetic mutation would have been written off as science fiction. It was the time of the Human Genome Project,...Show More Summary

This Just In: More Upgrades and Downgrades

New ratings for Level 3 Communications, Vivus, and Human Genome Sciences.

Copyright © 2011 Regator, LLC